Compare Cassava Sciences Inc (FLNA) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Procter & Gamble Co — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Procter & Gamble Co trades at $150.34 (market cap $344.75B). The key difference: Procter & Gamble Co is far larger — about 6487.6× Cassava Sciences Inc's market cap, and Procter & Gamble Co pays a 2.94% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | PG | |
|---|---|---|
Market Cap | $53.14M | $344.75B |
Sector | Health | Consumer Staples |
52-Week High | $4.64 | $167.18 |
52-Week Low | $1.09 | $138.10 |
Enterprise Value | -$33.43M | $370.23B |
Volume | — | 6,423,436 |
Dividend Yield | — | 2.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Procter & Gamble (PG) trades at $146.12, down 1.52% with bearish technical signals but strong fundamentals. The company maintains consistent revenue growth, with 2025 revenue reaching $84.28B and net income of $15.97B. Recent earnings have consistently beaten expectations, and analyst consensus remains positive with a $161.71 price target. Dividend payments continue with $1.09 per share payouts, supporting income-focused investors amid market volatility.
PG offers stability with 69 consecutive years of dividend growth and efficient cash flow generation, though premium valuation multiples and modest growth outlook present near-term headwinds. The stock's technical weakness contrasts with fundamental strength, creating potential for recovery if earnings momentum continues. Key risks include consumer demand softness and competitive pressures in the consumer staples sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
